Danish drugmaker Novo goes public with 2.6b euro bid for Belgium's Ablynx

Hong Kong

DANISH drugmaker Novo Nordisk A/S made its largest takeover offer ever, an unsolicited 2.6 billion euro (S$4.15 billion) bid for Belgium's Ablynx NV, to beef up its lesser known blood-disorder unit and rekindle growth.

The offer for Ablynx signals a higher appetite for deals at the world's biggest maker of diabetes medicines. A year after taking the reins, chief executive officer Lars Fruergaard Jorgensen is looking to exp…